DataLibraryResearch is tracking the market dynamics of the crisis in the Pharma & Healthcare industry amid lock-down changes in the supply chain.

Get detailed analysis of the COVID-19 impact on the Healthcare Contract Research Organization Market

Global Healthcare Contract Research Organization Market Opportunities and Forecast 2020-2027

  • DLR2660
  • 16 July, 2021
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Healthcare Contract Research Organization Market, By Type (Drug Discovery [Target Validation, Lead Identification, Lead Optimization], Pre-clinical, Clinical [Phase I Trial Services, Phase II Trial Services, Phase III Trial Services, Phase IV Trial Services], By Service (Project Management/Clinical Supply Management, Data Management, Regulatory/Medical Affairs, Medical Writing, Clinical Monitoring, Quality Management/ Assurance, Bio-statistics, Investigator Payments, Laboratory, Patient and Site Recruitment, Technology, Others) and opportunities and forecast 2020-2027.

Healthcare Contract Research Organization Market Overview

The global healthcare contract research organization (CRO) market is expected to rise by increased funding for research and development programs. Several key advancements in the field of disease study and drug development have played an important role in the market’s growth. As well, in the current time, it is observed that tremendous growth in the medical and pharmaceutical research institutes. This is owing to the pressing need to develop new lines of treatment for chronic diseases and disorders. This key fact remarkably contributes to the growth of the global healthcare contract research organization (CRO) market in the coming years.

Furthermore, the investment for the global healthcare contract research organization (CRO) market has improved in recent times. Governments and public-sector organizations have made large investments towards improved medical research. This prime fact further boosts the market’s development in the forecast period.

Healthcare Contract Research Organization Market Segment Overview

Based on the type, the clinical trial services segment dominated the market in 2020 and accounted for the largest revenue share in the market.  This is because it comprises four elaborate phases, including human subjects. Additionally, important factors such as the increasing need for innovative services within healthcare and the presence of a seamless industry for clinical trial and testing have played a curial role in the growth of the global healthcare contract research organization (CRO) market. Additionally, it is important to ensure the safety of research during drug development. This key fact will contribute to the market’s expansion in the forthcoming years.

Healthcare Contract Research Organization Market, By Type
  • Drug Discovery
    • Target Validation
    • Lead Identification
    • Lead Optimization
  • Pre-clinical
  • Clinical
    • Phase I Trial Services
    • Phase II Trial Services
    • Phase III Trial Services
  • Phase IV Trial Services
Healthcare Contract Research Organization Market, By Service

·       Project Management/Clinical Supply Management
·       Data Management
·       Regulatory/Medical Affairs
·       Medical Writing
·       Clinical Monitoring
·       Quality Management/ Assurance
·       Bio-statistics
·       Investigator Payments
·       Laboratory
·       Patient and Site Recruitment
·       Technology
·       Others

Healthcare Contract Research Organization Market Regional Overview

In terms of region, North America held a significant revenue share in 2020. This can be attributed to the presence of several global players, who invest a major part of their revenue in research activities. Likewise, the market for healthcare contract research organizations (CRO) in the Asia Pacific has been expanding owing to the increasing outsourcing of medical services to India and China.

Healthcare Contract Research Organization Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

Healthcare Contract Research Organization Market Competitor overview

Some key developments and strategies adopted by manufacturers in Healthcare Contract Research Organization are highlighted below.

·       In July 2021, Think Research Corporation, a company focused on transforming healthcare through digital health software solutions, announced that it has entered into a definitive share purchase agreement to acquire all of the issued and outstanding shares of Bio Pharma Services Inc., a leading contract research organization ("CRO") to pharmaceutical companies globally. This transaction is expected to nearly double the Company's pro forma 2021 revenue and presents significant new technology-driven revenue synergies for the combined entity.

Healthcare Contract Research Organization Market, Key Players

·       IQVIA Holdings Inc.
·       Covance Inc.
·       Pharmaceutical Product Development, LLC
·       Parexel International Corporation
·       Charles River Laboratories International, Inc.
·       ICON, plc
·       Medidata Solutions, Inc.
·       Syneos Health
·       Pharmaron
·       GVK Biosciences Private Limited
·       Wuxi AppTec
·       MEDPACE HOLDINGS, INC.
·       PRA Health Sciences
·       CTI Clinical Trial & Consulting

Healthcare Contract Research Organization Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Healthcare Contract Research Organization Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Type
        • 5.2.1. Drug Discovery
          • 5.2.1.1. Target Validation
          • 5.2.1.2. Lead Identification
          • 5.2.1.3. Lead Optimization
        • 5.2.2. Pre-clinical
        • 5.2.3. Clinical
          • 5.2.3.1. Phase I Trial Services
          • 5.2.3.2. Phase II Trial Services
          • 5.2.3.3. Phase III Trial Services
          • 5.2.3.4. Phase IV Trial Services
    • 5.3. Market Analysis, Insights and Forecast – By Service
      • 5.3.1. Project Management/Clinical Supply Management
      • 5.3.2. Data Management
      • 5.3.3. Regulatory/Medical Affairs
      • 5.3.4. Medical Writing
      • 5.3.5. Clinical Monitoring
      • 5.3.6. Quality Management/ Assurance
      • 5.3.7. Bio-statistics
      • 5.3.8. Investigator Payments
      • 5.3.9. Laboratory
      • 5.3.10. Patient and Site Recruitment
      • 5.3.11. Technology
      • 5.3.12. Others
    • 5.4. Market Analysis, Insights and Forecast – By Region
      • 5.4.1. North America
      • 5.4.2. Europe
      • 5.4.3. Asia Pacific
      • 5.4.4. Latin America, Middle East and Africa
    • 6. North America Healthcare Contract Research Organization Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Type
        • 6.2.1. Drug Discovery
          • 6.2.1.1. Target Validation
          • 6.2.1.2. Lead Identification
          • 6.2.1.3. Lead Optimization
        • 6.2.2. Pre-clinical
        • 6.2.3. Clinical
          • 6.2.3.1. Phase I Trial Services
          • 6.2.3.2. Phase II Trial Services
          • 6.2.3.3. Phase III Trial Services
          • 6.2.3.4. Phase IV Trial Services
    • 6.3. Market Analysis, Insights and Forecast – By Service
      • 6.3.1. Project Management/Clinical Supply Management
      • 6.3.2. Data Management
      • 6.3.3. Regulatory/Medical Affairs
      • 6.3.4. Medical Writing
      • 6.3.5. Clinical Monitoring
      • 6.3.6. Quality Management/ Assurance
      • 6.3.7. Bio-statistics
      • 6.3.8. Investigator Payments
      • 6.3.9. Laboratory
      • 6.3.10. Patient and Site Recruitment
      • 6.3.11. Technology
      • 6.3.12. Others
    • 6.4. Market Analysis, Insights and Forecast – By Country
      • 6.4.1. U.S.
      • 6.4.2. Canada
    • 7. Europe Healthcare Contract Research Organization Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Type
        • 7.2.1. Drug Discovery
          • 7.2.1.1. Target Validation
          • 7.2.1.2. Lead Identification
          • 7.2.1.3. Lead Optimization
        • 7.2.2. Pre-clinical
        • 7.2.3. Clinical
          • 7.2.3.1. Phase I Trial Services
          • 7.2.3.2. Phase II Trial Services
          • 7.2.3.3. Phase III Trial Services
          • 7.2.3.4. Phase IV Trial Services
    • 7.3. Market Analysis, Insights and Forecast – By Service
      • 7.3.1. Project Management/Clinical Supply Management
      • 7.3.2. Data Management
      • 7.3.3. Regulatory/Medical Affairs
      • 7.3.4. Medical Writing
      • 7.3.5. Clinical Monitoring
      • 7.3.6. Quality Management/ Assurance
      • 7.3.7. Bio-statistics
      • 7.3.8. Investigator Payments
      • 7.3.9. Laboratory
      • 7.3.10. Patient and Site Recruitment
      • 7.3.11. Technology
      • 7.3.12. Others
    • 7.4. Market Analysis, Insights and Forecast – By Country
      • 7.4.1. UK
      • 7.4.2. Germany
      • 7.4.3. France
      • 7.4.4. Italy
      • 7.4.5. Spain
      • 7.4.6. Russia
      • 7.4.7. Rest of Europe
    • 8. Asia Pacific Healthcare Contract Research Organization Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Type
        • 8.2.1. Drug Discovery
          • 8.2.1.1. Target Validation
          • 8.2.1.2. Lead Identification
          • 8.2.1.3. Lead Optimization
        • 8.2.2. Pre-clinical
        • 8.2.3. Clinical
          • 8.2.3.1. Phase I Trial Services
          • 8.2.3.2. Phase II Trial Services
          • 8.2.3.3. Phase III Trial Services
          • 8.2.3.4. Phase IV Trial Services
    • 8.3. Market Analysis, Insights and Forecast – By Service
      • 8.3.1. Project Management/Clinical Supply Management
      • 8.3.2. Data Management
      • 8.3.3. Regulatory/Medical Affairs
      • 8.3.4. Medical Writing
      • 8.3.5. Clinical Monitoring
      • 8.3.6. Quality Management/ Assurance
      • 8.3.7. Bio-statistics
      • 8.3.8. Investigator Payments
      • 8.3.9. Laboratory
      • 8.3.10. Patient and Site Recruitment
      • 8.3.11. Technology
      • 8.3.12. Others
    • 8.4. Market Analysis, Insights and Forecast – By Country
      • 8.4.1. China
      • 8.4.2. India
      • 8.4.3. Japan
      • 8.4.4. Australia
      • 8.4.5. South East Asia
      • 8.4.6. Rest of Asia Pacific
    • 9. Latin America, Middle East and Africa Healthcare Contract Research Organization Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Type
        • 9.2.1. Drug Discovery
          • 9.2.1.1. Target Validation
          • 9.2.1.2. Lead Identification
          • 9.2.1.3. Lead Optimization
        • 9.2.2. Pre-clinical
        • 9.2.3. Clinical
          • 9.2.3.1. Phase I Trial Services
          • 9.2.3.2. Phase II Trial Services
          • 9.2.3.3. Phase III Trial Services
          • 9.2.3.4. Phase IV Trial Services
    • 9.3. Market Analysis, Insights and Forecast – By Service
      • 9.3.1. Project Management/Clinical Supply Management
      • 9.3.2. Data Management
      • 9.3.3. Regulatory/Medical Affairs
      • 9.3.4. Medical Writing
      • 9.3.5. Clinical Monitoring
      • 9.3.6. Quality Management/ Assurance
      • 9.3.7. Bio-statistics
      • 9.3.8. Investigator Payments
      • 9.3.9. Laboratory
      • 9.3.10. Patient and Site Recruitment
      • 9.3.11. Technology
      • 9.3.12. Others
    • 9.4. Market Analysis, Insights and Forecast – By Country
      • 9.4.1. Brazil
      • 9.4.2. Saudi Arabia
      • 9.4.3. UAE
      • 9.4.4. Rest of LAMEA
    • 10. Competitive Analysis

      • 10.1. Company Market Share Analysis, 2018
      • 10.2. Key Industry Developments
      • 10.3. Company Profile
      • 10.4. IQVIA Holdings Inc.
        • 10.4.1. Business Overview
        • 10.4.2. Segment 1 & Service Offering
        • 10.4.3. Overall Revenue
        • 10.4.4. Geographic Presence
        • 10.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 10.5. Covance Inc.
      • 10.6. Pharmaceutical Product Development, LLC
      • 10.7. Parexel International Corporation
      • 10.8. Charles River Laboratories International, Inc.
      • 10.9. ICON, plc
      • 10.10. Medidata Solutions, Inc.
      • 10.11. Syneos Health
      • 10.12. Pharmaron
      • 10.13. GVK Biosciences Private Limited
      • 10.14. Wuxi AppTec
      • 10.15. MEDPACE HOLDINGS, INC.
      • 10.16. PRA Health Sciences

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      info@datalibraryresearch.com

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934